nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—ADRBK1—rheumatoid arthritis	0.579	0.823	CbGaD
Epinephrine—TNF—rheumatoid arthritis	0.124	0.177	CbGaD
Epinephrine—CYP1A2—Leflunomide—rheumatoid arthritis	0.0198	0.185	CbGbCtD
Epinephrine—CYP2C9—Leflunomide—rheumatoid arthritis	0.0179	0.167	CbGbCtD
Epinephrine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0115	0.107	CbGbCtD
Epinephrine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00847	0.079	CbGbCtD
Epinephrine—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00837	0.078	CbGbCtD
Epinephrine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00642	0.0598	CbGbCtD
Epinephrine—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00551	0.0514	CbGbCtD
Epinephrine—CYP3A4—Betamethasone—rheumatoid arthritis	0.00551	0.0513	CbGbCtD
Epinephrine—CYP3A4—Prednisolone—rheumatoid arthritis	0.00544	0.0507	CbGbCtD
Epinephrine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00515	0.048	CbGbCtD
Epinephrine—CYP3A4—Prednisone—rheumatoid arthritis	0.00513	0.0478	CbGbCtD
Epinephrine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00487	0.0454	CbGbCtD
Epinephrine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0032	0.0299	CbGbCtD
Epinephrine—Isoprenaline—ADRBK1—rheumatoid arthritis	0.00111	1	CrCbGaD
Epinephrine—Extravasation—Betamethasone—rheumatoid arthritis	0.000408	0.00621	CcSEcCtD
Epinephrine—Contusion—Betamethasone—rheumatoid arthritis	0.000408	0.00621	CcSEcCtD
Epinephrine—Contusion—Dexamethasone—rheumatoid arthritis	0.000408	0.00621	CcSEcCtD
Epinephrine—Hypokalaemia—Leflunomide—rheumatoid arthritis	0.000401	0.0061	CcSEcCtD
Epinephrine—Skin exfoliation—Hydrocortisone—rheumatoid arthritis	0.000398	0.00605	CcSEcCtD
Epinephrine—Necrosis—Prednisone—rheumatoid arthritis	0.000395	0.00601	CcSEcCtD
Epinephrine—Memory impairment—Prednisone—rheumatoid arthritis	0.000395	0.00601	CcSEcCtD
Epinephrine—Disorientation—Cyclosporine—rheumatoid arthritis	0.00038	0.00579	CcSEcCtD
Epinephrine—Pulmonary oedema—Prednisolone—rheumatoid arthritis	0.00038	0.00578	CcSEcCtD
Epinephrine—Skin exfoliation—Triamcinolone—rheumatoid arthritis	0.000375	0.0057	CcSEcCtD
Epinephrine—Skin exfoliation—Methylprednisolone—rheumatoid arthritis	0.000374	0.00568	CcSEcCtD
Epinephrine—Sweating increased—Leflunomide—rheumatoid arthritis	0.000371	0.00565	CcSEcCtD
Epinephrine—Pulmonary oedema—Hydrocortisone—rheumatoid arthritis	0.000371	0.00564	CcSEcCtD
Epinephrine—Renal impairment—Cyclosporine—rheumatoid arthritis	0.000358	0.00544	CcSEcCtD
Epinephrine—Contusion—Prednisone—rheumatoid arthritis	0.000355	0.0054	CcSEcCtD
Epinephrine—Pulmonary oedema—Triamcinolone—rheumatoid arthritis	0.000349	0.00531	CcSEcCtD
Epinephrine—Hypoglycaemia—Cyclosporine—rheumatoid arthritis	0.000349	0.0053	CcSEcCtD
Epinephrine—Pulmonary oedema—Methylprednisolone—rheumatoid arthritis	0.000348	0.0053	CcSEcCtD
Epinephrine—Nausea—Ergocalciferol—rheumatoid arthritis	0.000348	0.00529	CcSEcCtD
Epinephrine—Hyperglycaemia—Leflunomide—rheumatoid arthritis	0.000344	0.00523	CcSEcCtD
Epinephrine—Skin exfoliation—Dexamethasone—rheumatoid arthritis	0.00034	0.00517	CcSEcCtD
Epinephrine—Skin exfoliation—Betamethasone—rheumatoid arthritis	0.00034	0.00517	CcSEcCtD
Epinephrine—Renal failure—Leflunomide—rheumatoid arthritis	0.000334	0.00508	CcSEcCtD
Epinephrine—Necrosis—Methotrexate—rheumatoid arthritis	0.00033	0.00502	CcSEcCtD
Epinephrine—Haemoglobin—Azathioprine—rheumatoid arthritis	0.000325	0.00494	CcSEcCtD
Epinephrine—Haemorrhage—Azathioprine—rheumatoid arthritis	0.000323	0.00491	CcSEcCtD
Epinephrine—Pulmonary oedema—Betamethasone—rheumatoid arthritis	0.000317	0.00482	CcSEcCtD
Epinephrine—Pulmonary oedema—Dexamethasone—rheumatoid arthritis	0.000317	0.00482	CcSEcCtD
Epinephrine—Haemoglobin—Leflunomide—rheumatoid arthritis	0.000307	0.00466	CcSEcCtD
Epinephrine—Haemorrhage—Leflunomide—rheumatoid arthritis	0.000305	0.00464	CcSEcCtD
Epinephrine—Vomiting—Auranofin—rheumatoid arthritis	0.000304	0.00462	CcSEcCtD
Epinephrine—Extravasation—Methotrexate—rheumatoid arthritis	0.000297	0.00452	CcSEcCtD
Epinephrine—Skin exfoliation—Prednisone—rheumatoid arthritis	0.000296	0.0045	CcSEcCtD
Epinephrine—Psychotic disorder—Hydrocortisone—rheumatoid arthritis	0.000295	0.00449	CcSEcCtD
Epinephrine—Arrhythmia—Azathioprine—rheumatoid arthritis	0.000289	0.00439	CcSEcCtD
Epinephrine—Sweating increased—Cyclosporine—rheumatoid arthritis	0.000287	0.00436	CcSEcCtD
Epinephrine—Nausea—Auranofin—rheumatoid arthritis	0.000284	0.00431	CcSEcCtD
Epinephrine—Vomiting—Penicillamine—rheumatoid arthritis	0.00028	0.00426	CcSEcCtD
Epinephrine—Psychotic disorder—Methylprednisolone—rheumatoid arthritis	0.000278	0.00422	CcSEcCtD
Epinephrine—Pulmonary oedema—Prednisone—rheumatoid arthritis	0.000276	0.0042	CcSEcCtD
Epinephrine—Hypokalaemia—Hydrocortisone—rheumatoid arthritis	0.000275	0.00419	CcSEcCtD
Epinephrine—Arrhythmia—Leflunomide—rheumatoid arthritis	0.000273	0.00414	CcSEcCtD
Epinephrine—Mental disorder—Leflunomide—rheumatoid arthritis	0.000267	0.00406	CcSEcCtD
Epinephrine—Hyperglycaemia—Cyclosporine—rheumatoid arthritis	0.000265	0.00404	CcSEcCtD
Epinephrine—Nausea—Penicillamine—rheumatoid arthritis	0.000262	0.00398	CcSEcCtD
Epinephrine—Sweating increased—Prednisolone—rheumatoid arthritis	0.000261	0.00397	CcSEcCtD
Epinephrine—Acute coronary syndrome—Cyclosporine—rheumatoid arthritis	0.000259	0.00393	CcSEcCtD
Epinephrine—Renal failure—Cyclosporine—rheumatoid arthritis	0.000258	0.00392	CcSEcCtD
Epinephrine—Myocardial infarction—Cyclosporine—rheumatoid arthritis	0.000257	0.00391	CcSEcCtD
Epinephrine—Sweating increased—Hydrocortisone—rheumatoid arthritis	0.000255	0.00387	CcSEcCtD
Epinephrine—Psychotic disorder—Dexamethasone—rheumatoid arthritis	0.000252	0.00384	CcSEcCtD
Epinephrine—Psychotic disorder—Betamethasone—rheumatoid arthritis	0.000252	0.00384	CcSEcCtD
Epinephrine—Skin exfoliation—Methotrexate—rheumatoid arthritis	0.000247	0.00376	CcSEcCtD
Epinephrine—Sweating increased—Triamcinolone—rheumatoid arthritis	0.00024	0.00365	CcSEcCtD
Epinephrine—Sweating increased—Methylprednisolone—rheumatoid arthritis	0.000239	0.00364	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.000238	0.00362	CcSEcCtD
Epinephrine—Haemoglobin—Cyclosporine—rheumatoid arthritis	0.000237	0.0036	CcSEcCtD
Epinephrine—Haemorrhage—Cyclosporine—rheumatoid arthritis	0.000235	0.00358	CcSEcCtD
Epinephrine—Acute coronary syndrome—Prednisolone—rheumatoid arthritis	0.000235	0.00358	CcSEcCtD
Epinephrine—Hypokalaemia—Betamethasone—rheumatoid arthritis	0.000235	0.00358	CcSEcCtD
Epinephrine—Hypokalaemia—Dexamethasone—rheumatoid arthritis	0.000235	0.00358	CcSEcCtD
Epinephrine—Palpitations—Leflunomide—rheumatoid arthritis	0.000235	0.00357	CcSEcCtD
Epinephrine—Hypoaesthesia—Cyclosporine—rheumatoid arthritis	0.000234	0.00356	CcSEcCtD
Epinephrine—Myocardial infarction—Prednisolone—rheumatoid arthritis	0.000234	0.00356	CcSEcCtD
Epinephrine—Pulmonary oedema—Methotrexate—rheumatoid arthritis	0.000231	0.00351	CcSEcCtD
Epinephrine—Acute coronary syndrome—Hydrocortisone—rheumatoid arthritis	0.00023	0.00349	CcSEcCtD
Epinephrine—Hypertension—Leflunomide—rheumatoid arthritis	0.000229	0.00349	CcSEcCtD
Epinephrine—Myocardial infarction—Hydrocortisone—rheumatoid arthritis	0.000228	0.00347	CcSEcCtD
Epinephrine—Chest pain—Leflunomide—rheumatoid arthritis	0.000226	0.00344	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000225	0.00341	CcSEcCtD
Epinephrine—Skin disorder—Azathioprine—rheumatoid arthritis	0.000223	0.00339	CcSEcCtD
Epinephrine—Psychotic disorder—Prednisone—rheumatoid arthritis	0.00022	0.00334	CcSEcCtD
Epinephrine—Flushing—Cyclosporine—rheumatoid arthritis	0.000219	0.00332	CcSEcCtD
Epinephrine—Sweating increased—Dexamethasone—rheumatoid arthritis	0.000218	0.00331	CcSEcCtD
Epinephrine—Sweating increased—Betamethasone—rheumatoid arthritis	0.000218	0.00331	CcSEcCtD
Epinephrine—Acute coronary syndrome—Triamcinolone—rheumatoid arthritis	0.000216	0.00329	CcSEcCtD
Epinephrine—Acute coronary syndrome—Methylprednisolone—rheumatoid arthritis	0.000216	0.00328	CcSEcCtD
Epinephrine—Haemoglobin—Prednisolone—rheumatoid arthritis	0.000215	0.00327	CcSEcCtD
Epinephrine—Myocardial infarction—Triamcinolone—rheumatoid arthritis	0.000215	0.00327	CcSEcCtD
Epinephrine—Myocardial infarction—Methylprednisolone—rheumatoid arthritis	0.000215	0.00326	CcSEcCtD
Epinephrine—Haemorrhage—Prednisolone—rheumatoid arthritis	0.000214	0.00326	CcSEcCtD
Epinephrine—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000213	0.00323	CcSEcCtD
Epinephrine—Tachycardia—Leflunomide—rheumatoid arthritis	0.000212	0.00322	CcSEcCtD
Epinephrine—Skin disorder—Leflunomide—rheumatoid arthritis	0.000211	0.0032	CcSEcCtD
Epinephrine—Arrhythmia—Cyclosporine—rheumatoid arthritis	0.00021	0.0032	CcSEcCtD
Epinephrine—Haemoglobin—Hydrocortisone—rheumatoid arthritis	0.00021	0.0032	CcSEcCtD
Epinephrine—Sweating—Methylprednisolone—rheumatoid arthritis	0.00021	0.00319	CcSEcCtD
Epinephrine—Hyperhidrosis—Leflunomide—rheumatoid arthritis	0.00021	0.00319	CcSEcCtD
Epinephrine—Haemorrhage—Hydrocortisone—rheumatoid arthritis	0.000209	0.00318	CcSEcCtD
Epinephrine—Hallucination—Hydrocortisone—rheumatoid arthritis	0.000208	0.00317	CcSEcCtD
Epinephrine—Mental disorder—Cyclosporine—rheumatoid arthritis	0.000206	0.00314	CcSEcCtD
Epinephrine—Hypokalaemia—Prednisone—rheumatoid arthritis	0.000205	0.00311	CcSEcCtD
Epinephrine—Hyperglycaemia—Dexamethasone—rheumatoid arthritis	0.000201	0.00306	CcSEcCtD
Epinephrine—Hyperglycaemia—Betamethasone—rheumatoid arthritis	0.000201	0.00306	CcSEcCtD
Epinephrine—Tension—Cyclosporine—rheumatoid arthritis	0.000201	0.00306	CcSEcCtD
Epinephrine—Nervousness—Cyclosporine—rheumatoid arthritis	0.000199	0.00303	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000198	0.00301	CcSEcCtD
Epinephrine—Haemoglobin—Triamcinolone—rheumatoid arthritis	0.000198	0.00301	CcSEcCtD
Epinephrine—Haemoglobin—Methylprednisolone—rheumatoid arthritis	0.000198	0.003	CcSEcCtD
Epinephrine—Haemorrhage—Triamcinolone—rheumatoid arthritis	0.000197	0.003	CcSEcCtD
Epinephrine—Haemorrhage—Methylprednisolone—rheumatoid arthritis	0.000197	0.00299	CcSEcCtD
Epinephrine—Acute coronary syndrome—Dexamethasone—rheumatoid arthritis	0.000196	0.00299	CcSEcCtD
Epinephrine—Acute coronary syndrome—Betamethasone—rheumatoid arthritis	0.000196	0.00299	CcSEcCtD
Epinephrine—Insomnia—Leflunomide—rheumatoid arthritis	0.000196	0.00298	CcSEcCtD
Epinephrine—Hallucination—Methylprednisolone—rheumatoid arthritis	0.000196	0.00297	CcSEcCtD
Epinephrine—Myocardial infarction—Betamethasone—rheumatoid arthritis	0.000195	0.00297	CcSEcCtD
Epinephrine—Myocardial infarction—Dexamethasone—rheumatoid arthritis	0.000195	0.00297	CcSEcCtD
Epinephrine—Paraesthesia—Leflunomide—rheumatoid arthritis	0.000195	0.00296	CcSEcCtD
Epinephrine—Cerebrovascular accident—Methotrexate—rheumatoid arthritis	0.000192	0.00292	CcSEcCtD
Epinephrine—Arrhythmia—Prednisolone—rheumatoid arthritis	0.000191	0.00291	CcSEcCtD
Epinephrine—Sweating increased—Prednisone—rheumatoid arthritis	0.000189	0.00288	CcSEcCtD
Epinephrine—Agitation—Cyclosporine—rheumatoid arthritis	0.000188	0.00286	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000187	0.00285	CcSEcCtD
Epinephrine—Arrhythmia—Hydrocortisone—rheumatoid arthritis	0.000187	0.00284	CcSEcCtD
Epinephrine—Erythema—Prednisolone—rheumatoid arthritis	0.000187	0.00284	CcSEcCtD
Epinephrine—Mental disorder—Hydrocortisone—rheumatoid arthritis	0.000183	0.00279	CcSEcCtD
Epinephrine—Erythema—Hydrocortisone—rheumatoid arthritis	0.000182	0.00277	CcSEcCtD
Epinephrine—Haemoglobin—Betamethasone—rheumatoid arthritis	0.00018	0.00273	CcSEcCtD
Epinephrine—Haemoglobin—Dexamethasone—rheumatoid arthritis	0.00018	0.00273	CcSEcCtD
Epinephrine—Haemorrhage—Betamethasone—rheumatoid arthritis	0.000179	0.00272	CcSEcCtD
Epinephrine—Haemorrhage—Dexamethasone—rheumatoid arthritis	0.000179	0.00272	CcSEcCtD
Epinephrine—Hallucination—Dexamethasone—rheumatoid arthritis	0.000178	0.00271	CcSEcCtD
Epinephrine—Hallucination—Betamethasone—rheumatoid arthritis	0.000178	0.00271	CcSEcCtD
Epinephrine—Hypertension—Cyclosporine—rheumatoid arthritis	0.000177	0.00269	CcSEcCtD
Epinephrine—Arrhythmia—Triamcinolone—rheumatoid arthritis	0.000176	0.00268	CcSEcCtD
Epinephrine—Arrhythmia—Methylprednisolone—rheumatoid arthritis	0.000176	0.00267	CcSEcCtD
Epinephrine—Hyperglycaemia—Prednisone—rheumatoid arthritis	0.000175	0.00267	CcSEcCtD
Epinephrine—Chest pain—Cyclosporine—rheumatoid arthritis	0.000174	0.00265	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000173	0.00264	CcSEcCtD
Epinephrine—Mental disorder—Methylprednisolone—rheumatoid arthritis	0.000172	0.00262	CcSEcCtD
Epinephrine—Erythema—Triamcinolone—rheumatoid arthritis	0.000172	0.00261	CcSEcCtD
Epinephrine—Erythema—Methylprednisolone—rheumatoid arthritis	0.000171	0.0026	CcSEcCtD
Epinephrine—Acute coronary syndrome—Prednisone—rheumatoid arthritis	0.000171	0.0026	CcSEcCtD
Epinephrine—Myocardial infarction—Prednisone—rheumatoid arthritis	0.00017	0.00259	CcSEcCtD
Epinephrine—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000164	0.00249	CcSEcCtD
Epinephrine—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000162	0.00247	CcSEcCtD
Epinephrine—Hyperhidrosis—Cyclosporine—rheumatoid arthritis	0.000162	0.00246	CcSEcCtD
Epinephrine—Hypertension—Prednisolone—rheumatoid arthritis	0.000161	0.00245	CcSEcCtD
Epinephrine—Arrhythmia—Betamethasone—rheumatoid arthritis	0.00016	0.00243	CcSEcCtD
Epinephrine—Arrhythmia—Dexamethasone—rheumatoid arthritis	0.00016	0.00243	CcSEcCtD
Epinephrine—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000157	0.00239	CcSEcCtD
Epinephrine—Haemoglobin—Prednisone—rheumatoid arthritis	0.000156	0.00238	CcSEcCtD
Epinephrine—Haemorrhage—Prednisone—rheumatoid arthritis	0.000156	0.00237	CcSEcCtD
Epinephrine—Erythema—Betamethasone—rheumatoid arthritis	0.000156	0.00237	CcSEcCtD
Epinephrine—Erythema—Dexamethasone—rheumatoid arthritis	0.000156	0.00237	CcSEcCtD
Epinephrine—Hallucination—Prednisone—rheumatoid arthritis	0.000155	0.00236	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000154	0.00234	CcSEcCtD
Epinephrine—Dizziness—Azathioprine—rheumatoid arthritis	0.000152	0.00231	CcSEcCtD
Epinephrine—Insomnia—Cyclosporine—rheumatoid arthritis	0.000151	0.0023	CcSEcCtD
Epinephrine—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.00015	0.00228	CcSEcCtD
Epinephrine—Somnolence—Cyclosporine—rheumatoid arthritis	0.000149	0.00226	CcSEcCtD
Epinephrine—Tachycardia—Prednisolone—rheumatoid arthritis	0.000149	0.00226	CcSEcCtD
Epinephrine—Hypertension—Triamcinolone—rheumatoid arthritis	0.000148	0.00225	CcSEcCtD
Epinephrine—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000148	0.00225	CcSEcCtD
Epinephrine—Hyperhidrosis—Prednisolone—rheumatoid arthritis	0.000147	0.00224	CcSEcCtD
Epinephrine—Vomiting—Azathioprine—rheumatoid arthritis	0.000146	0.00222	CcSEcCtD
Epinephrine—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000146	0.00222	CcSEcCtD
Epinephrine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000145	0.00221	CcSEcCtD
Epinephrine—Drowsiness—Methotrexate—rheumatoid arthritis	0.000145	0.0022	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000145	0.0022	CcSEcCtD
Epinephrine—Flushing—Prednisone—rheumatoid arthritis	0.000144	0.0022	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000144	0.0022	CcSEcCtD
Epinephrine—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000144	0.0022	CcSEcCtD
Epinephrine—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	0.000144	0.00219	CcSEcCtD
Epinephrine—Dizziness—Leflunomide—rheumatoid arthritis	0.000143	0.00218	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—rheumatoid arthritis	0.000142	0.00217	CcSEcCtD
Epinephrine—Arrhythmia—Prednisone—rheumatoid arthritis	0.000139	0.00212	CcSEcCtD
Epinephrine—Sweating—Methotrexate—rheumatoid arthritis	0.000139	0.00211	CcSEcCtD
Epinephrine—Vomiting—Leflunomide—rheumatoid arthritis	0.000138	0.0021	CcSEcCtD
Epinephrine—Insomnia—Prednisolone—rheumatoid arthritis	0.000138	0.00209	CcSEcCtD
Epinephrine—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000137	0.00208	CcSEcCtD
Epinephrine—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000137	0.00208	CcSEcCtD
Epinephrine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000137	0.00208	CcSEcCtD
Epinephrine—Mental disorder—Prednisone—rheumatoid arthritis	0.000136	0.00207	CcSEcCtD
Epinephrine—Nausea—Azathioprine—rheumatoid arthritis	0.000136	0.00207	CcSEcCtD
Epinephrine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000136	0.00207	CcSEcCtD
Epinephrine—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000136	0.00206	CcSEcCtD
Epinephrine—Erythema—Prednisone—rheumatoid arthritis	0.000136	0.00206	CcSEcCtD
Epinephrine—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000135	0.00206	CcSEcCtD
Epinephrine—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000135	0.00205	CcSEcCtD
Epinephrine—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000134	0.00204	CcSEcCtD
Epinephrine—Hypertension—Betamethasone—rheumatoid arthritis	0.000134	0.00204	CcSEcCtD
Epinephrine—Hypertension—Dexamethasone—rheumatoid arthritis	0.000134	0.00204	CcSEcCtD
Epinephrine—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000133	0.00203	CcSEcCtD
Epinephrine—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000131	0.00199	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—rheumatoid arthritis	0.00013	0.00198	CcSEcCtD
Epinephrine—Nausea—Leflunomide—rheumatoid arthritis	0.000129	0.00196	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000128	0.00195	CcSEcCtD
Epinephrine—Insomnia—Triamcinolone—rheumatoid arthritis	0.000127	0.00193	CcSEcCtD
Epinephrine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000126	0.00192	CcSEcCtD
Epinephrine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000126	0.00191	CcSEcCtD
Epinephrine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000125	0.00191	CcSEcCtD
Epinephrine—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000125	0.00189	CcSEcCtD
Epinephrine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000125	0.00189	CcSEcCtD
Epinephrine—Agitation—Prednisone—rheumatoid arthritis	0.000125	0.00189	CcSEcCtD
Epinephrine—Tachycardia—Betamethasone—rheumatoid arthritis	0.000124	0.00189	CcSEcCtD
Epinephrine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000124	0.00189	CcSEcCtD
Epinephrine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000123	0.00187	CcSEcCtD
Epinephrine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000123	0.00187	CcSEcCtD
Epinephrine—Hypertension—Prednisone—rheumatoid arthritis	0.000117	0.00178	CcSEcCtD
Epinephrine—Insomnia—Dexamethasone—rheumatoid arthritis	0.000115	0.00175	CcSEcCtD
Epinephrine—Insomnia—Betamethasone—rheumatoid arthritis	0.000115	0.00175	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000115	0.00174	CcSEcCtD
Epinephrine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000114	0.00173	CcSEcCtD
Epinephrine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000114	0.00173	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—rheumatoid arthritis	0.000114	0.00173	CcSEcCtD
Epinephrine—Erythema—Methotrexate—rheumatoid arthritis	0.000113	0.00172	CcSEcCtD
Epinephrine—Dizziness—Cyclosporine—rheumatoid arthritis	0.000111	0.00168	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00011	0.00167	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00011	0.00167	CcSEcCtD
Epinephrine—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000108	0.00165	CcSEcCtD
Epinephrine—Tachycardia—Prednisone—rheumatoid arthritis	0.000108	0.00164	CcSEcCtD
Epinephrine—Skin disorder—Prednisone—rheumatoid arthritis	0.000107	0.00163	CcSEcCtD
Epinephrine—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000107	0.00163	CcSEcCtD
Epinephrine—Vomiting—Cyclosporine—rheumatoid arthritis	0.000106	0.00162	CcSEcCtD
Epinephrine—Dizziness—Prednisolone—rheumatoid arthritis	0.000101	0.00153	CcSEcCtD
Epinephrine—Insomnia—Prednisone—rheumatoid arthritis	0.0001	0.00152	CcSEcCtD
Epinephrine—Nausea—Cyclosporine—rheumatoid arthritis	9.94e-05	0.00151	CcSEcCtD
Epinephrine—Paraesthesia—Prednisone—rheumatoid arthritis	9.93e-05	0.00151	CcSEcCtD
Epinephrine—Dizziness—Hydrocortisone—rheumatoid arthritis	9.83e-05	0.00149	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—rheumatoid arthritis	9.64e-05	0.00147	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.58e-05	0.00146	CcSEcCtD
Epinephrine—Vomiting—Hydrocortisone—rheumatoid arthritis	9.45e-05	0.00144	CcSEcCtD
Epinephrine—Dizziness—Triamcinolone—rheumatoid arthritis	9.26e-05	0.00141	CcSEcCtD
Epinephrine—Dizziness—Methylprednisolone—rheumatoid arthritis	9.24e-05	0.0014	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—rheumatoid arthritis	9.07e-05	0.00138	CcSEcCtD
Epinephrine—Nausea—Prednisolone—rheumatoid arthritis	9.04e-05	0.00137	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—rheumatoid arthritis	8.98e-05	0.00137	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	8.94e-05	0.00136	CcSEcCtD
Epinephrine—Vomiting—Triamcinolone—rheumatoid arthritis	8.9e-05	0.00135	CcSEcCtD
Epinephrine—Vomiting—Methylprednisolone—rheumatoid arthritis	8.88e-05	0.00135	CcSEcCtD
Epinephrine—Nausea—Hydrocortisone—rheumatoid arthritis	8.83e-05	0.00134	CcSEcCtD
Epinephrine—Dizziness—Betamethasone—rheumatoid arthritis	8.4e-05	0.00128	CcSEcCtD
Epinephrine—Dizziness—Dexamethasone—rheumatoid arthritis	8.4e-05	0.00128	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—rheumatoid arthritis	8.36e-05	0.00127	CcSEcCtD
Epinephrine—Nausea—Triamcinolone—rheumatoid arthritis	8.31e-05	0.00126	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—rheumatoid arthritis	8.3e-05	0.00126	CcSEcCtD
Epinephrine—Nausea—Methylprednisolone—rheumatoid arthritis	8.3e-05	0.00126	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—rheumatoid arthritis	8.22e-05	0.00125	CcSEcCtD
Epinephrine—Vomiting—Dexamethasone—rheumatoid arthritis	8.08e-05	0.00123	CcSEcCtD
Epinephrine—Vomiting—Betamethasone—rheumatoid arthritis	8.08e-05	0.00123	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.98e-05	0.00121	CcSEcCtD
Epinephrine—Nausea—Dexamethasone—rheumatoid arthritis	7.54e-05	0.00115	CcSEcCtD
Epinephrine—Nausea—Betamethasone—rheumatoid arthritis	7.54e-05	0.00115	CcSEcCtD
Epinephrine—Dizziness—Prednisone—rheumatoid arthritis	7.31e-05	0.00111	CcSEcCtD
Epinephrine—Vomiting—Prednisone—rheumatoid arthritis	7.03e-05	0.00107	CcSEcCtD
Epinephrine—Nausea—Prednisone—rheumatoid arthritis	6.57e-05	0.000999	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—rheumatoid arthritis	6.11e-05	0.00093	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—rheumatoid arthritis	5.88e-05	0.000894	CcSEcCtD
Epinephrine—Nausea—Methotrexate—rheumatoid arthritis	5.49e-05	0.000835	CcSEcCtD
Epinephrine—ADRB2—Signaling Pathways—IL2RA—rheumatoid arthritis	4.88e-06	3.97e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2—rheumatoid arthritis	4.84e-06	3.94e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—C3—rheumatoid arthritis	4.84e-06	3.94e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP3—rheumatoid arthritis	4.82e-06	3.92e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SPP1—rheumatoid arthritis	4.82e-06	3.92e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—TYK2—rheumatoid arthritis	4.81e-06	3.92e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.79e-06	3.91e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.79e-06	3.9e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	4.78e-06	3.9e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—FN1—rheumatoid arthritis	4.77e-06	3.88e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6ST—rheumatoid arthritis	4.75e-06	3.87e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SPP1—rheumatoid arthritis	4.74e-06	3.86e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.72e-06	3.84e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.7e-06	3.83e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCR5—rheumatoid arthritis	4.68e-06	3.82e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.67e-06	3.8e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.67e-06	3.8e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MMP9—rheumatoid arthritis	4.66e-06	3.8e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTK2—rheumatoid arthritis	4.64e-06	3.78e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2RA—rheumatoid arthritis	4.62e-06	3.76e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.62e-06	3.76e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NFKB1—rheumatoid arthritis	4.61e-06	3.76e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCR5—rheumatoid arthritis	4.61e-06	3.76e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—LEP—rheumatoid arthritis	4.6e-06	3.75e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—rheumatoid arthritis	4.58e-06	3.73e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—C3—rheumatoid arthritis	4.58e-06	3.73e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CD80—rheumatoid arthritis	4.57e-06	3.72e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—LEP—rheumatoid arthritis	4.56e-06	3.72e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL5—rheumatoid arthritis	4.55e-06	3.7e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2RA—rheumatoid arthritis	4.54e-06	3.7e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MAPK8—rheumatoid arthritis	4.53e-06	3.69e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—rheumatoid arthritis	4.51e-06	3.67e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—C3—rheumatoid arthritis	4.51e-06	3.67e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—LEP—rheumatoid arthritis	4.5e-06	3.67e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—POMC—rheumatoid arthritis	4.5e-06	3.67e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CSF2—rheumatoid arthritis	4.48e-06	3.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	4.47e-06	3.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	4.47e-06	3.64e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	4.45e-06	3.62e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—rheumatoid arthritis	4.41e-06	3.59e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.41e-06	3.59e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—POMC—rheumatoid arthritis	4.38e-06	3.57e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—FN1—rheumatoid arthritis	4.34e-06	3.54e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—POMC—rheumatoid arthritis	4.34e-06	3.54e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6ST—rheumatoid arthritis	4.32e-06	3.52e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	4.31e-06	3.51e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—FN1—rheumatoid arthritis	4.3e-06	3.51e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.29e-06	3.49e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6ST—rheumatoid arthritis	4.29e-06	3.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—LEP—rheumatoid arthritis	4.26e-06	3.47e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL2—rheumatoid arthritis	4.25e-06	3.46e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—FN1—rheumatoid arthritis	4.25e-06	3.46e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6R—rheumatoid arthritis	4.23e-06	3.45e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6ST—rheumatoid arthritis	4.23e-06	3.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	4.22e-06	3.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	4.21e-06	3.43e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	4.2e-06	3.42e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—POMC—rheumatoid arthritis	4.2e-06	3.42e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—LEP—rheumatoid arthritis	4.19e-06	3.42e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.19e-06	3.41e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—rheumatoid arthritis	4.19e-06	3.41e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	4.16e-06	3.39e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CD80—rheumatoid arthritis	4.16e-06	3.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	4.16e-06	3.39e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	4.12e-06	3.36e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.11e-06	3.35e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ALB—rheumatoid arthritis	4.1e-06	3.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	4.1e-06	3.34e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	4.1e-06	3.34e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	4.09e-06	3.33e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CD80—rheumatoid arthritis	4.07e-06	3.32e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	4.04e-06	3.29e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FN1—rheumatoid arthritis	4.02e-06	3.27e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.02e-06	3.27e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	4.01e-06	3.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6ST—rheumatoid arthritis	4e-06	3.26e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	4e-06	3.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ALB—rheumatoid arthritis	3.99e-06	3.25e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—POMC—rheumatoid arthritis	3.96e-06	3.22e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FN1—rheumatoid arthritis	3.96e-06	3.22e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—rheumatoid arthritis	3.94e-06	3.21e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6ST—rheumatoid arthritis	3.94e-06	3.21e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—NOS3—rheumatoid arthritis	3.93e-06	3.2e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	3.92e-06	3.19e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	3.91e-06	3.19e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.89e-06	3.17e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL2—rheumatoid arthritis	3.87e-06	3.15e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—POMC—rheumatoid arthritis	3.87e-06	3.15e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.87e-06	3.15e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6R—rheumatoid arthritis	3.86e-06	3.14e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TYK2—rheumatoid arthritis	3.86e-06	3.14e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	3.85e-06	3.14e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—rheumatoid arthritis	3.84e-06	3.13e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	3.83e-06	3.12e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ALB—rheumatoid arthritis	3.83e-06	3.12e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	3.82e-06	3.11e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	3.82e-06	3.11e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	3.8e-06	3.1e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CD80—rheumatoid arthritis	3.79e-06	3.09e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NOS3—rheumatoid arthritis	3.79e-06	3.08e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL2—rheumatoid arthritis	3.79e-06	3.08e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6R—rheumatoid arthritis	3.77e-06	3.07e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	3.75e-06	3.05e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	3.73e-06	3.04e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	3.72e-06	3.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	3.72e-06	3.03e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	3.66e-06	2.98e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—NOS3—rheumatoid arthritis	3.66e-06	2.98e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—rheumatoid arthritis	3.61e-06	2.94e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—POMC—rheumatoid arthritis	3.6e-06	2.94e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—rheumatoid arthritis	3.59e-06	2.92e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	3.58e-06	2.92e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	3.57e-06	2.91e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—POMC—rheumatoid arthritis	3.56e-06	2.9e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL2—rheumatoid arthritis	3.53e-06	2.87e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.52e-06	2.86e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6R—rheumatoid arthritis	3.51e-06	2.86e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TYK2—rheumatoid arthritis	3.51e-06	2.86e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	3.51e-06	2.86e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	3.5e-06	2.85e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	3.49e-06	2.84e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	3.48e-06	2.84e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	3.46e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOS3—rheumatoid arthritis	3.45e-06	2.81e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CAT—rheumatoid arthritis	3.44e-06	2.8e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TYK2—rheumatoid arthritis	3.44e-06	2.8e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	3.42e-06	2.78e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOS3—rheumatoid arthritis	3.37e-06	2.75e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	3.37e-06	2.74e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL8—rheumatoid arthritis	3.36e-06	2.74e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—rheumatoid arthritis	3.35e-06	2.73e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	3.26e-06	2.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	3.25e-06	2.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	3.25e-06	2.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—rheumatoid arthritis	3.24e-06	2.64e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—rheumatoid arthritis	3.21e-06	2.61e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	3.2e-06	2.61e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	3.2e-06	2.61e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—rheumatoid arthritis	3.19e-06	2.6e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	3.19e-06	2.6e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—rheumatoid arthritis	3.16e-06	2.58e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	3.15e-06	2.57e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	3.14e-06	2.56e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	3.13e-06	2.55e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	3.13e-06	2.55e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	3.12e-06	2.54e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	3.1e-06	2.53e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL8—rheumatoid arthritis	3.06e-06	2.49e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—rheumatoid arthritis	3.04e-06	2.47e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	3.03e-06	2.47e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NFKB1—rheumatoid arthritis	3.01e-06	2.45e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL8—rheumatoid arthritis	2.99e-06	2.44e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	2.97e-06	2.42e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK8—rheumatoid arthritis	2.95e-06	2.41e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	2.94e-06	2.4e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—rheumatoid arthritis	2.92e-06	2.38e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—rheumatoid arthritis	2.91e-06	2.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	2.91e-06	2.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	2.9e-06	2.36e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	2.9e-06	2.36e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—rheumatoid arthritis	2.9e-06	2.36e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	2.88e-06	2.35e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	2.87e-06	2.34e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—rheumatoid arthritis	2.86e-06	2.33e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—rheumatoid arthritis	2.85e-06	2.32e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	2.84e-06	2.32e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	2.84e-06	2.31e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	2.83e-06	2.31e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	2.79e-06	2.27e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	2.79e-06	2.27e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—rheumatoid arthritis	2.77e-06	2.25e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	2.74e-06	2.23e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.74e-06	2.23e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—rheumatoid arthritis	2.73e-06	2.22e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	2.71e-06	2.21e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—rheumatoid arthritis	2.71e-06	2.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	2.71e-06	2.2e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	2.69e-06	2.19e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.69e-06	2.19e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NFKB1—rheumatoid arthritis	2.68e-06	2.18e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	2.67e-06	2.17e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	2.66e-06	2.17e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	2.65e-06	2.16e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	2.64e-06	2.15e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK8—rheumatoid arthritis	2.63e-06	2.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	2.59e-06	2.11e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	2.56e-06	2.09e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	2.53e-06	2.06e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	2.52e-06	2.05e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—rheumatoid arthritis	2.5e-06	2.04e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	2.49e-06	2.03e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	2.49e-06	2.03e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.49e-06	2.02e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.48e-06	2.02e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	2.46e-06	2.01e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	2.45e-06	2e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	2.45e-06	2e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.43e-06	1.98e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	2.37e-06	1.93e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	2.35e-06	1.92e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.3e-06	1.87e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	2.3e-06	1.87e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—POMC—rheumatoid arthritis	2.3e-06	1.87e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.28e-06	1.86e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.27e-06	1.85e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	2.26e-06	1.84e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.26e-06	1.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	2.24e-06	1.82e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—rheumatoid arthritis	2.23e-06	1.82e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.22e-06	1.8e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	2.2e-06	1.79e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	2.19e-06	1.78e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.18e-06	1.77e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	2.11e-06	1.72e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—rheumatoid arthritis	2.09e-06	1.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	2.08e-06	1.7e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.08e-06	1.69e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—rheumatoid arthritis	2.06e-06	1.68e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.06e-06	1.68e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.02e-06	1.65e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.01e-06	1.64e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	2e-06	1.63e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.96e-06	1.6e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.89e-06	1.54e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—rheumatoid arthritis	1.89e-06	1.54e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—rheumatoid arthritis	1.88e-06	1.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.87e-06	1.52e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	1.86e-06	1.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.85e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—rheumatoid arthritis	1.84e-06	1.5e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.83e-06	1.49e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.79e-06	1.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	1.74e-06	1.42e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—rheumatoid arthritis	1.72e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.71e-06	1.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	1.71e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	1.71e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	1.7e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—rheumatoid arthritis	1.68e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	1.59e-06	1.3e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	1.57e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	1.57e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	1.52e-06	1.24e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.52e-06	1.23e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	1.41e-06	1.15e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	1.39e-06	1.13e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.38e-06	1.13e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.32e-06	1.08e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	1.29e-06	1.05e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.21e-06	9.84e-06	CbGpPWpGaD
